Stemtech (STEK) Change in Accured Expenses (2012 - 2025)

Stemtech has disclosed Change in Accured Expenses across 14 years of filings, most recently posting -$361521.0 for Q2 2025.

• Change in Accured Expenses for Q2 2025 came in at -$361521.0, up 67.19% year-over-year; the trailing twelve-month figure through Sep 2025 was -$66866.0 (down 151.92% YoY), and the FY2024 annual result was -$66866.0, down 106.99% from the prior year.
• Change in Accured Expenses came in at -$361521.0 for Q2 2025 at Stemtech, down from $361521.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $1.2 million in Q4 2021 to a low of -$1.1 million in Q2 2024.
• The 5-year median for Change in Accured Expenses is $128793.0 (2023), against an average of $83821.4.
• Across the five-year window, Change in Accured Expenses jumped 605.7% in 2022 and plunged 494.89% in 2024, its largest moves.
• Stemtech's Change in Accured Expenses stood at $1.2 million in 2021, then slumped by 189.56% to -$1.1 million in 2022, then surged by 111.82% to $128793.0 in 2023, then plunged by 151.92% to -$66866.0 in 2024, then sank by 440.66% to -$361521.0 in 2025.
• The last three Change in Accured Expenses figures came in at -$361521.0 (Q2 2025), $361521.0 (Q1 2025), and -$66866.0 (Q4 2024), per Business Quant data.